Bli medlem
Bli medlem

Du är här


Orexo: Number of shares and votes in Orexo

Uppsala, Sweden - January 31, 2017 - The number of shares and votes in
Orexo AB has changed as a result of the exercise of warrants in
connection with the company's incentive programs.

Today, the last trading day of the month, there are in total
34,874,585 shares - whereof 34,539,585 are ordinary shares and
335,000 class C shares - and 34,573,085 votes in the company.

For further information, please contact:

Orexo AB (publ.)

Lena Wange, IR & Communications Manager
Tel: 018 780 88 00

About Orexo

Orexo is a specialty pharmaceutical company commercializing its
proprietary product Zubsolv® for treatment of opioid dependence in
the US. Zubsolv is an advanced formulation of buprenorphine and
naloxone using Orexo's unique knowledge and expertise in sublingual
drug delivery. R&D is focusing on reformulation of known substances
to new improved products that meet great unmet medical needs by using
its patented proprietary technologies. Orexo's share is listed on
Nasdaq Stockholm Exchange Mid Cap (STO: ORX) and is available as ADRs
on OTCQX (ORXOY) in the US. Orexo's global headquarters and R&D are
based in Uppsala, Sweden.

For more information about Orexo, please visit or follow
us on Twitter or LinkedIn. For further information about Zubsolv in
the US, please visit

The information was submitted for publication at 5:45pm CET, January
31, 2017


Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.